During the past decade, Duquesne University Center for Pharmacy Care conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Duquesne University Center for Pharmacy Care" #1 collaborator was "Warner Chilcott" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Duquesne University Center for Pharmacy Care" are "Osteopenia" (2 trials) and "Osteoporosis" (2 trials). Many other conditions were trialed in "Duquesne University Center for Pharmacy Care" in a lesser frequency.

Most popular intervention types in "Duquesne University Center for Pharmacy Care" are "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "FRAX Assessment Tool" (1 trials), "Fiber Pill" (1 trials) and "Melatonin, Strontium citrate, Vitamins D3 and K2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Duquesne University Center for Pharmacy Care" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Duquesne University Center for Pharmacy Care". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Duquesne University Center for Pharmacy Care, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Duquesne University Center for Pharmacy Care, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".